BioMarin Pharmaceutical Inc. buy Raymond James
Start price
10.10.24
/
50%
€63.66
Target price
10.10.25
€72.21
Performance (%)
-28.37%
End price
11.10.25
€45.60
Summary
This prediction ended on 11.10.25 with a price of €45.60. The price of BioMarin Pharmaceutical Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -28.37%. Raymond_James has a follow-up prediction for BioMarin Pharmaceutical Inc. where he still thinks BioMarin Pharmaceutical Inc. is a Buy. Raymond_James has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| BioMarin Pharmaceutical Inc. | 2.356% | 2.356% | 5.452% |
| iShares Core DAX® | 2,99 % | 3,22 % | 4,27 % |
| iShares Nasdaq 100 | -1,58 % | -3,17 % | 24,75 % |
| iShares Nikkei 225® | -2,25 % | -9,92 % | 43,52 % |
| iShares S&P 500 | -0,01 % | 1,64 % | 20,97 % |
Comments by Raymond_James for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its "outperform" rating re-affirmed by analysts at Raymond James. They now have a $79.00 price target on the stock.
Ratings data for BMRN provided by MarketBeat
In the thread Trading BioMarin Pharmaceutical Inc.
Die von Raymond_James gewählte maximale Laufzeit wurde überschritten
Current prediction by Raymond_James for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€51.00
03.09.25
03.09.25
€73.07
03.09.26
03.09.26
6.75%
15:38
15:38
